Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.33 |
| ▸ | CHRNA10 | Q9GZZ6 | 4/20 | 0.33 |
| ▸ | CHRNA9 | Q9UGM1 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601077 | 0.78 | CHRNA7 (0.37) | MEN1NPC1KMT2ARAB9ALMNA | |
| SCHEMBL21202127 | 0.72 | CHRNA7 (0.43) | NPC1RAB9ALMNAHTTSMN1; SMN2 | |
| SCHEMBL19601091 | 0.71 | ALDH1A1 (0.55) | RAB9ALMNAHTTSMN1; SMN2KDM4E | |
| SCHEMBL19601099 | 0.70 | BCHE (0.39) | — | |
| SCHEMBL19601104 | 0.67 | ALDH1A1 (0.58) | RAB9ALMNAHTTSMN1; SMN2KDM4E | |
| SCHEMBL21202131 | 0.67 | ACHE (0.47) | RAB9ALMNAHTTSMN1; SMN2KDM4E | |
| SCHEMBL5295848 | 0.66 | CHRNA7 (0.50) | MEN1NPC1KMT2ARAB9ALMNA | |
| SCHEMBL19601084 | 0.66 | MEN1 (0.44) | MEN1NPC1KMT2ARAB9ALMNA | |
| SCHEMBL27254225 | 0.65 | HDAC8 (0.42) | MEN1NPC1KMT2ARAB9AXDH | |
| SCHEMBL19601103 | 0.65 | KDM4A (0.43) | RAB9ACHRNA7CHRNA10CHRNA9KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10364223-B2 | Organic compound, electrochromic element, optical filter, lens unit, image pickup apparatus, and window member | CANON KABUSHIKI KAISHA (JP) | 2019-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10364223-B2 | Organic compound, electrochromic element, optical filter, lens unit, image pickup apparatus, and window member | EML4, AP2M1, AP2A2 | MEN1 1520/4885NPC1 1836/4885KMT2A 3416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.